US SB658 | 2017-2018 | 115th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on March 15 2017 - 25% progression, died in committee
Action: 2017-03-15 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Illegal Synthetic Drug Safety Act of 2017 This bill amends the Controlled Substances Act to modify the treatment of controlled substance analogues (i.e., substances that have substantially similar chemical structures and pharmacological effects to schedule I controlled substances). Under current law, a controlled substance analogue that is intended for human consumption is treated as a schedule I controlled substance. This bill replaces the "intended for human consumption" qualifier with a "not a chemical substance subject to the Toxic Substances Control Act" qualifier. Specifically, a controlled substance analogue that is not a chemical substance under the Toxic Substances Control Act is treated as a schedule I controlled substance.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Illegal Synthetic Drug Safety Act of 2017

Sponsors


History

DateChamberAction
2017-03-15SenateRead twice and referred to the Committee on the Judiciary.

Subjects


US Congress State Sources


Bill Comments

feedback